{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "24260479", "DateCompleted": {"Year": "2014", "Month": "08", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"Language": ["eng"], "ELocationID": ["e80782", "10.1371/journal.pone.0080782"], "ArticleDate": [{"Year": "2013", "Month": "11", "Day": "18"}], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "8", "Issue": "11", "PubDate": {"Year": "2013"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Effects of N-acetylcysteine in ozone-induced chronic obstructive pulmonary disease model.", "Pagination": {"StartPage": "e80782", "MedlinePgn": "e80782"}, "Abstract": {"AbstractText": ["Chronic exposure to high levels of ozone induces emphysema and chronic inflammation in mice. We determined the recovery from ozone-induced injury and whether an antioxidant, N-acetylcysteine (NAC), could prevent or reverse the lung damage.", "Mice were exposed to ozone (2.5 ppm, 3 hours/12 exposures, over 6 weeks) and studied 24 hours (24h) or 6 weeks (6W) later. Nac (100 mg/kg, intraperitoneally) was administered either before each exposure (preventive) or after completion of exposure (therapeutic) for 6 weeks.", "After ozone exposure, there was an increase in functional residual capacity, total lung volume, and lung compliance, and a reduction in the ratio of forced expiratory volume at 25 and 50 milliseconds to forced vital capacity (FEV25/FVC, FEV50/FVC). Mean linear intercept (Lm) and airway hyperresponsiveness (AHR) to acetylcholine increased, and remained unchanged at 6W after cessation of exposure. Preventive NAC reduced the number of BAL macrophages and airway smooth muscle (ASM) mass. Therapeutic NAC reversed AHR, and reduced ASM mass and apoptotic cells.", "Emphysema and lung function changes were irreversible up to 6W after cessation of ozone exposure, and were not reversed by NAC. The beneficial effects of therapeutic NAC may be restricted to the ASM."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Studies Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom ; Department of Respiratory Medicine, the Affiliated First People's Hospital of Shanghai Jiao Tong University, Shanghai, P.R. China."}], "Identifier": [], "LastName": "Li", "ForeName": "Feng", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wiegman", "ForeName": "Cornelis", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Seiffert", "ForeName": "Joanna M", "Initials": "JM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhu", "ForeName": "Jie", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Clarke", "ForeName": "Colin", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chang", "ForeName": "Yan", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bhavsar", "ForeName": "Pank", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Adcock", "ForeName": "Ian", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Junfeng", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "Xin", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "Kian Fan", "Initials": "KF"}], "GrantList": [{"Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "083905", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Expectorants"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "88847-89-6", "NameOfSubstance": "8-Hydroxy-2'-Deoxyguanosine"}, {"RegistryNumber": "G9481N71RO", "NameOfSubstance": "Deoxyguanosine"}, {"RegistryNumber": "WYQ7N0BPYC", "NameOfSubstance": "Acetylcysteine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "8-Hydroxy-2'-Deoxyguanosine"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Acetylcysteine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["chemistry", "cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["analogs & derivatives", "blood"], "DescriptorName": "Deoxyguanosine"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["pathology"], "DescriptorName": "Emphysema"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Expectorants"}, {"QualifierName": [], "DescriptorName": "Gene Expression"}, {"QualifierName": ["drug effects", "metabolism", "pathology", "physiopathology"], "DescriptorName": "Lung"}, {"QualifierName": ["metabolism"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced", "pathology", "prevention & control"], "DescriptorName": "Pulmonary Disease, Chronic Obstructive"}, {"QualifierName": [], "DescriptorName": "Respiratory Function Tests"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist.\n"}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "\nChung KF, Adcock IM (2008) Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J\n31: 1334-1356. doi:10.1183/09031936.00018908. PubMed: 18515558.", "ArticleIdList": ["10.1183/09031936.00018908", "18515558"]}, {"Citation": "\nDecramer M, Janssens W, Miravitlles M (2012) Chronic obstructive pulmonary disease. Lancet\n379: 1341-1351. S0140- doi:10.1016/S0140-6736(11)60968-9. PubMed: 22314182. 6736(11)60968-9 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1016/S0140-6736(11)60968-9\n", "ArticleIdList": ["10.1016/S0140-6736(11)60968-9", "10.1016/S0140-6736(11)60968-9", "PMC7172377", "22314182"]}, {"Citation": "\nCiencewicki J, Trivedi S, Kleeberger SR (2008) Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol\n122: 456-468. S0091- doi:10.1016/j.jaci.2008.08.004. PubMed: 18774381. 6749(08)01485-1 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1016/j.jaci.2008.08.004\n", "ArticleIdList": ["10.1016/j.jaci.2008.08.004", "10.1016/j.jaci.2008.08.004", "PMC2693323", "18774381"]}, {"Citation": "\nChung KF, Marwick JA (2010) Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci\n1203: 85-91. doi:10.1111/j.1749-6632.2010.05600.x. PubMed: 20716288.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05600.x", "20716288"]}, {"Citation": "\nTriantaphyllopoulos K, Hussain F, Pinart M, Zhang M, Li F\net al. (2011) A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. Am J Physiol Lung Cell Mol Physiol\n300: L691-L700. doi:10.1152/ajplung.00252.2010. PubMed: 21355040. ajplung.00252.2010 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1152/ajplung.00252.2010\n", "ArticleIdList": ["10.1152/ajplung.00252.2010", "10.1152/ajplung.00252.2010", "PMC3094024", "21355040"]}, {"Citation": "\nTuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I (2006) State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc\n3: 503-510. doi:10.1513/pats.200603-054MS. PubMed: 16921129. 3/6/503 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1513/pats.200603-054MS\n", "ArticleIdList": ["10.1513/pats.200603-054MS", "10.1513/pats.200603-054MS", "PMC2647641", "16921129"]}, {"Citation": "\nChurg A, Cosio M, Wright JL (2008) Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol, 294: 294: L612-L631 PubMed: 18223159. 00390.2007 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1152/ajplung.00390.2007\n", "ArticleIdList": ["10.1152/ajplung.00390.2007", "18223159"]}, {"Citation": "\nRahman I, Macnee W (2012) Antioxidant pharmacological therapies for COPD. Curr Opin Pharmacol, 12: S1471-S4892. PubMed: 22349417. 12)00016-1 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1016/j.coph.2012.01.015\n", "ArticleIdList": ["10.1016/j.coph.2012.01.015", "PMC3768007", "22349417"]}, {"Citation": "\nMillea PJ (2009) N-acetylcysteine: multiple clinical applications. Am Fam Physician\n80: 265-269. PubMed: 19621836.", "ArticleIdList": ["19621836"]}, {"Citation": "\nRubio ML, Martin-Mosquero MC, Ortega M, Peces-Barba G, Gonz\u00e1lez-Mangado N (2004) Oral N-acetylcysteine attenuates elastase-induced pulmonary emphysema in rats. Chest\n125: 1500-1506. doi:10.1378/chest.125.4.1500. PubMed: 15078764.", "ArticleIdList": ["10.1378/chest.125.4.1500", "15078764"]}, {"Citation": "\nMarch TH, Wilder JA, Esparza DC, Cossey PY, Blair LF\net al. (2006) Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci\n92: 545-559. doi:10.1093/toxsci/kfl016. PubMed: 16699168. kfl016 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1093/toxsci/kfl016\n", "ArticleIdList": ["10.1093/toxsci/kfl016", "10.1093/toxsci/kfl016", "16699168"]}, {"Citation": "\nKatre A, Ballinger C, Akhter H, Fanucchi M, Kim DK\net al. (2011) Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice. Inhal Toxicol\n23: 486-494. doi:10.3109/08958378.2011.584919. PubMed: 21689010.", "ArticleIdList": ["10.3109/08958378.2011.584919", "PMC3690533", "21689010"]}, {"Citation": "\nBraber S, Henricks PA, Nijkamp FP, Kraneveld AD, Folkerts G; Braber S, Henricks PA, Nijkamp FP, Kraneveld AD, Folkerts G (2010) Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir Res\n11: 99: 1465-9921-11-99 PubMed: 20649997. PII];10.1186/1465-9921-11-99 [doi]. PubMed: 20649997.", "ArticleIdList": ["PMC2918562", "20649997"]}, {"Citation": "\nChakrabarti S, Patel KD (2005) Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res\n31: 599-621. doi:10.1080/019021490944232. PubMed: 16019990. L147KJ228LL24236 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1080/019021490944232\n", "ArticleIdList": ["10.1080/019021490944232", "10.1080/019021490944232", "16019990"]}, {"Citation": "\nLin JL, Thomas PS (2010) Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD\n7: 291-306. doi:10.3109/15412555.2010.496818. PubMed: 20673039.", "ArticleIdList": ["10.3109/15412555.2010.496818", "20673039"]}, {"Citation": "Scichilone N, Battaglia S, La SA, Bellia V (2006) Clinical implications of airway hyperresponsiveness in COPD. Int J Chron Obstruct Pulmon Dis 1: 49-60 PubMed; : 18046902", "ArticleIdList": ["PMC2706603", "18046902"]}, {"Citation": "\nvan den Berge M, Vonk JM, Gosman M, Lapperre TS, Snoeck-Stroband JB\net al. (2012) Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. Eur Respir J, 40: 1098\u2013105. PubMed: 22523354.", "ArticleIdList": ["22523354"]}, {"Citation": "\nWilliams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P\net al. (2007) Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol\n103: 1189-1195. doi:10.1152/japplphysiol.00172.2007. PubMed: 17626835. 00172.2007 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1152/japplphysiol.00172.2007\n", "ArticleIdList": ["10.1152/japplphysiol.00172.2007", "10.1152/japplphysiol.00172.2007", "17626835"]}, {"Citation": "\nWilliams AS, Nath P, Leung SY, Khorasani N, McKenzie AN\net al. (2008) Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13. Eur Respir J\n32: 571-578. doi:10.1183/09031936.00121607. PubMed: 18417511. 09031936.00121607 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1183/09031936.00121607\n", "ArticleIdList": ["10.1183/09031936.00121607", "10.1183/09031936.00121607", "18417511"]}, {"Citation": "\nLi F, Zhang M, Hussain F, Triantaphyllopoulos K, Clark AR\net al. (2011) Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids. Eur Respir J\n37: 933-942. doi:10.1183/09031936.00021110. PubMed: 20693246. 09031936.00021110 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1183/09031936.00021110\n", "ArticleIdList": ["10.1183/09031936.00021110", "10.1183/09031936.00021110", "PMC3331993", "20693246"]}, {"Citation": "\nHeld HD, Uhlig S (2000) Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice. Am J Respir Crit Care Med\n162: 1547-1552. doi:10.1164/ajrccm.162.4.9912079. PubMed: 11029375.", "ArticleIdList": ["10.1164/ajrccm.162.4.9912079", "11029375"]}, {"Citation": "\nSch\u00fctze N, Lehmann I, B\u00f6nisch U, Simon JC, Polte T (2010) Exposure to mycotoxins increases the allergic immune response in a murine asthma model. Am J Respir Crit Care Med\n181: 1188-1199. doi:10.1164/rccm.200909-1350OC. PubMed: 20194814. 200909-1350OC . PII;Retrieved onpublished at whilst December year 1111 from \n10.1164/rccm.200909-1350OC\n", "ArticleIdList": ["10.1164/rccm.200909-1350OC", "10.1164/rccm.200909-1350OC", "20194814"]}, {"Citation": "\nTighe RM, Li Z, Potts EN, Frush S, Liu N\net al. (2011) Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation. J Immunol\n187: 4800-4808. doi:10.4049/jimmunol.1101312. PubMed: 21930959. jimmunol.1101312 . PII;Retrieved onpublished at whilst December year 1111 from \n10.4049/jimmunol.1101312\n", "ArticleIdList": ["10.4049/jimmunol.1101312", "10.4049/jimmunol.1101312", "PMC3197861", "21930959"]}, {"Citation": "\nPotts-Kant EN, Li Z, Tighe RM, Lindsey JY, Frush BW\net al. (2012) NAD(P)H:quinone oxidoreductase 1 protects lungs from oxidant-induced emphysema in mice. Free Radic Biol Med\n52: 705-715. S0891- doi:10.1016/j.freeradbiomed.2011.11.027. PubMed: 22198263. 5849(11)01214-7 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1016/j.freeradbiomed.2011.11.027\n", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.11.027", "10.1016/j.freeradbiomed.2011.11.027", "PMC3267893", "22198263"]}, {"Citation": "\nHeili FS, Del Puerto-Nevado L, P\u00e9rez-Rial S, Martin-Mosquero C, Ortega et al. (2008) Improving the cadmium-induced centriacinar emphysema model in rats by concomitant anti-oxidant treatment. Clin Exp Pharmacol Physiol\n35: 1337-1342. doi:10.1111/j.1440-1681.2008.05026.x. PubMed: 18759863. CEP5026 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1111/j.1440-1681.2008.05026.x\n", "ArticleIdList": ["10.1111/j.1440-1681.2008.05026.x", "10.1111/j.1440-1681.2008.05026.x", "18759863"]}, {"Citation": "\nCai S, Chen P, Zhang C, Chen JB, Wu J (2009) Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats. Respirology\n14: 354-359. doi:10.1111/j.1440-1843.2009.01511.x. PubMed: 19341424. RES1511 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1111/j.1440-1843.2009.01511.x\n", "ArticleIdList": ["10.1111/j.1440-1843.2009.01511.x", "10.1111/j.1440-1843.2009.01511.x", "19341424"]}, {"Citation": "\nKohansal R, Martinez-Camblor P, Agust\u00ed A, Buist AS, Mannino DM\net al. (2009) The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med\n180: 3-10. doi:10.1164/rccm.200901-0047OC. PubMed: 19342411. 200901-0047OC . PII;Retrieved onpublished at whilst December year 1111 from \n10.1164/rccm.200901-0047OC\n", "ArticleIdList": ["10.1164/rccm.200901-0047OC", "10.1164/rccm.200901-0047OC", "19342411"]}, {"Citation": "\nWillemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Timens W\net al. (2004) Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD. Eur Respir J\n24: 391-396. doi:10.1183/09031936.04.00117603. PubMed: 15358697. 24/3/391. PII.", "ArticleIdList": ["10.1183/09031936.04.00117603", "15358697"]}, {"Citation": "\nMiller M, Cho JY, Pham A, Friedman PJ, Ramsdell J\net al. (2011) Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years. Chest\n139: 1380-1387. doi:10.1378/chest.10-0705. PubMed: 20966041. chest.10-0705 . PII;Retrieved onpublished at whilst December year 1111 from \n10.1378/chest.10-0705\n", "ArticleIdList": ["10.1378/chest.10-0705", "10.1378/chest.10-0705", "PMC3109645", "20966041"]}]}], "History": [{"Year": "2013", "Month": "6", "Day": "12"}, {"Year": "2013", "Month": "10", "Day": "7"}, {"Year": "2013", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "11", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "8", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "11", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["24260479", "PMC3832609", "10.1371/journal.pone.0080782", "PONE-D-13-24416"]}}], "PubmedBookArticle": []}